We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Complaints Rising on Pharma Comparative Claim Violations
Complaints Rising on Pharma Comparative Claim Violations
October 1, 2012
A sharp increase in exaggerated or misleading comparative claims in drug advertisements has the FDA analyzing the issue and considering guidance on it to help stop the violations.